期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (6)
Background: A higher red blood cell distribution width (RDW) predicts major adverse cardiac events in patients with coronary artery disease (CAD). How......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (6)
Objective: The objective of this study is to compare the efficacy and safety of thrombolysis plus anticoagulant therapy vs. anticoagulant therapy alon......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (5)
Background Atrial arrhythmias are associated with an increased risk of stroke and death in the elderly. The risk and predictive factors of recurrent a......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (1)
Background: Takayasu Arteritis (TAK) is a rare autoimmune vasculitis that predominantly affects the aorta and its major branches, including the corona......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (6)
Background: Pericardial Effusion (PEf) can occur with Acute Heart Failure (AHF). Objective: To evaluate the effect of PEf size on the prognosis of pat......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (6)
Aims: To explore treatment with Direct Oral Anticoagulants (DOACs) in left ventricular thrombus (LVT) after ST-segment elevation myocardial infarction......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2022; 20 (2)
Background: Given its close anatomical location to the heart and its endocrine properties, attention on epicardial adipose tissue (EAT) has increased.......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2021; 19 (4)
Aims: This study aims to explore early intensive lipid-lowering therapy in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). ......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2021; 19 (4)
Coronary artery spasm (CAS) plays an important role in the pathogenesis of ischemic heart disease. The clinical manifestations of CAS include variant ......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2021; 19 (1)
Background: The research on the association between the relative glycemic level postpercutaneous coronary intervention (PCI) and adverse prognosis in ......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2021; 19 (4)
Nicotinic acetylcholine receptors (nAChRs) comprise a large family of ligand-gated ion channels that have a broad distribution in neurons and non-neur......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2020; 18 (4)
Background: Aging-associated vascular dysfunction promotes cardiovascular diseases. Recently, Ginkgo biloba extract (GBE) has attracted considerable a......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2020; 18 (1)
Background: Takayasu's arteritis (TA) is a large-vessel vasculitis that predominantly affects the aorta, pulmonary artery, and its main branches. The ......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2020; 18 (4)
Background: Alzheimer's disease (AD) and vascular dementia (VaD) are major types of dementia, both of which cause heavy economic burdens for families ......
期刊: CURRENT VASCULAR PHARMACOLOGY, 2020; 18 (4)
Background: Uncaria rhynchophylla (Miq.) Jacks (Rubinaceae), a common herbal medicine known as Gou-teng in Chinese, is commonly used in Chinese medici......